Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 16,305 | 13,166 | 75,082 | 0 | 0 |
| Cost of Goods | 536 | 580 | 4,136 | 0 | N/A |
| Gross Profit | 15,769 | 12,586 | 70,946 | 0 | N/A |
| Operating Expenses | 12,987 | 12,229 | 46,338 | 469 | 391 |
| Operating Income | 2,782 | 357 | 24,608 | -469 | -391 |
| Interest Expense | 5,640 | 5,704 | N/A | N/A | N/A |
| Other Income | 1,985 | -298 | -24,611 | 69 | 55 |
| Pre-tax Income | -873 | -5,645 | -4 | -401 | -337 |
| Income Tax | -310 | -769 | 5,228 | -83 | -88 |
| Net Income Continuous | -563 | -4,876 | -5,231 | -318 | -249 |
| Net Income | $-563 | $-4,876 | $-5,231 | $-318 | $-249 |
| EPS Basic Total Ops | -0.02 | -0.19 | -0.40 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.19 | -0.40 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.19 | -0.40 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.19 | -0.40 | -0.02 | -0.02 |
| EBITDA(a) | $21,042 | $8,200 | $23,533 | $-469 | $-391 |